Cidara Therapeutics Inc.
01/09/2026 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005782 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Cidara Therapeutics Inc. published this content on January 09, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 12, 2026 at 16:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]